Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Karl Jacobsen

Showing results (21-30 of 55) with videos related to

Pageof 6
Sort By:
Journal of Diabetes and Its Complications|August 13, 2023
Risk of atrial fibrillation in individuals with dysglycemia and diabetesRasmus Rørth, Margit Kriegbaum, Mia Klinten Grand, et al.
Peptides|January 28, 2025
Transcardiac gradients of pro-cholecystokinin, cholecystokinin, and gastrin in patients with and without heart failure with reduced ejection fractionTania Deis, Benedicte Heegaard, Kasper Rossing, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 21, 2024
Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillatorDiana My Frodi, Søren Zöga Diederichsen, Lucas Yixi Xing, et al.
Journal of Diabetes and Its Complications|December 15, 2015
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuriaBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 15, 2013
Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD RegisterPeter Weeke, Jens Brock Johansen, Ole Dan Jørgensen, et al.
Plos One|April 27, 2018
Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up studyMarie Frimodt-Møller, Bernt Johan von Scholten, Henrik Reinhard, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 17, 2020
Risk of arrhythmias after myocardial infarction in patients with left ventricular systolic dysfunction according to mode of revascularization: a Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction (CARISMA) substudyAnna F Thomsen, Peter Karl Jacobsen, Lars Køber, et al.
Journal of Diabetes and Its Complications|May 1, 2020
Lipoprotein(a)and renal function decline, cardiovascular disease and mortality in type 2 diabetes and microalbuminuriaNiels Sondergaard Heinrich, Bernt Johan von Scholten, Henrik Reinhard, et al.
Acta Diabetologica|August 15, 2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patientsViktor Rotbain Curovic, Tine W Hansen, Mie K Eickhoff, et al.
Cardiovascular Diabetology|May 21, 2015
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetesBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.
Pageof 6

Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Diabetes and Its Complications|August 13, 2023
Risk of atrial fibrillation in individuals with dysglycemia and diabetesRasmus Rørth, Margit Kriegbaum, Mia Klinten Grand, et al.
Peptides|January 28, 2025
Transcardiac gradients of pro-cholecystokinin, cholecystokinin, and gastrin in patients with and without heart failure with reduced ejection fractionTania Deis, Benedicte Heegaard, Kasper Rossing, et al.
Journal of Interventional Cardiac Electrophysiology : an International Journal of Arrhythmias and Pacing|August 21, 2024
Incidence and risk factors for first and recurrent ICD shock therapy in patients with an implantable cardioverter defibrillatorDiana My Frodi, Søren Zöga Diederichsen, Lucas Yixi Xing, et al.
Journal of Diabetes and Its Complications|December 15, 2015
Markers of inflammation and endothelial dysfunction are associated with incident cardiovascular disease, all-cause mortality, and progression of coronary calcification in type 2 diabetic patients with microalbuminuriaBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|February 15, 2013
Mortality and appropriate and inappropriate therapy in patients with ischaemic heart disease and implanted cardioverter-defibrillators for primary prevention: data from the Danish ICD RegisterPeter Weeke, Jens Brock Johansen, Ole Dan Jørgensen, et al.
Plos One|April 27, 2018
Growth differentiation factor-15 and fibroblast growth factor-23 are associated with mortality in type 2 diabetes - An observational follow-up studyMarie Frimodt-Møller, Bernt Johan von Scholten, Henrik Reinhard, et al.
Europace : European Pacing, Arrhythmias, and Cardiac Electrophysiology : Journal of the Working Groups on Cardiac Pacing, Arrhythmias, and Cardiac Cellular Electrophysiology of the European Society of Cardiology|November 17, 2020
Risk of arrhythmias after myocardial infarction in patients with left ventricular systolic dysfunction according to mode of revascularization: a Cardiac Arrhythmias and RIsk Stratification after Myocardial infArction (CARISMA) substudyAnna F Thomsen, Peter Karl Jacobsen, Lars Køber, et al.
Journal of Diabetes and Its Complications|May 1, 2020
Lipoprotein(a)and renal function decline, cardiovascular disease and mortality in type 2 diabetes and microalbuminuriaNiels Sondergaard Heinrich, Bernt Johan von Scholten, Henrik Reinhard, et al.
Acta Diabetologica|August 15, 2018
Urinary tubular biomarkers as predictors of kidney function decline, cardiovascular events and mortality in microalbuminuric type 2 diabetic patientsViktor Rotbain Curovic, Tine W Hansen, Mie K Eickhoff, et al.
Cardiovascular Diabetology|May 21, 2015
Additive prognostic value of plasma N-terminal pro-brain natriuretic peptide and coronary artery calcification for cardiovascular events and mortality in asymptomatic patients with type 2 diabetesBernt Johan von Scholten, Henrik Reinhard, Tine Willum Hansen, et al.
Pageof 6